Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2026-02-24 @ 12:14 AM
Study NCT ID:
NCT04278092
Status:
COMPLETED
Last Update Posted:
2025-05-08
First Post:
2020-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure
Sponsor:
Medical University of Vienna
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PACE ACE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None